Ascelia Pharma AB (CHIX:ACEs)
kr 3.29 (0%) Market Cap: 400.61 Mil Enterprise Value: 367.41 Mil PE Ratio: 0 PB Ratio: 4.59 GF Score: 37/100

Q1 2026 Ascelia Pharma AB Earnings Presentation Transcript

May 13, 2026 / 09:00 AM GMT
Release Date Price: kr45.05


Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

ACELP.ST - Ascelia Pharma AB
Q1 2026 Ascelia Pharma AB Earnings Presentation
May 13, 2026 / 09:00AM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Welcome to today's event where we have the pleasure to present Escalia Pharma to help us through today's presentation and ask and answer questions. In the end, we are joined by CEO Maurus Korvitsen.

Today's agenda, of course, your Q1-26 results may be a little bit pale through all the new flow and the very important time you're going into with about two months to present the due date.

I think we will cover that probably more. And there's a lot of questions on the partner side, so that we will also take at the end of the presentation. There's a box down below already came a lot in on the partner side to see if you have something, a new angle, then ask, but I think we're pretty good covered there. But for now, I'll
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot